Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05099549
Title Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors NKGen Biotech, Inc.
Indications

head and neck squamous cell carcinoma

colorectal cancer

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

AFM24 + SNK01

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST